| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/05/2009 | US20090060874 Bicyclic pyrrolidine derivatives |
| 03/05/2009 | US20090058261 Carbazole derivative, and light emitting element material, light emitting element, and electronic appliance obtained using the same |
| 03/05/2009 | DE102007041116A1 1,3-Dihydro-isoindolderivate 1,3-dihydro-isoindolderivate |
| 03/05/2009 | CA2697971A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/05/2009 | CA2697724A1 Method for splitting omeprazole salts |
| 03/05/2009 | CA2697663A1 Substituted pyrazole derivative |
| 03/05/2009 | CA2697382A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators |
| 03/05/2009 | CA2697167A1 Benzimidazole derivatives used as fxr agonists |
| 03/05/2009 | CA2696799A1 Piperidine derivative |
| 03/05/2009 | CA2696767A1 Heterocyclic amides useful for the treatment of cancer and psoriasis |
| 03/05/2009 | CA2694911A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| 03/04/2009 | EP2030973A1 Process for preparing 2-sulfinyl-1H-benzimidazoles |
| 03/04/2009 | EP2030970A1 Allosteric modulators of metabotropic glutamate receptors |
| 03/04/2009 | EP2030621A1 Novel substituted pyrimidines as cysteine protease inhibitors |
| 03/04/2009 | EP2029581A1 P38 inhibitors and methods of use thereof |
| 03/04/2009 | EP2029577A2 Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline |
| 03/04/2009 | EP2029576A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 03/04/2009 | EP2029575A1 Substituted spirocyclic cgrp receptor antagonists |
| 03/04/2009 | EP2029574A1 Novel method for preparation of ammonium salts of esomeprazole |
| 03/04/2009 | EP2029573A1 Dibenzorylenetetracarboximides as infrared absorbers |
| 03/04/2009 | EP2029572A2 Organic compounds |
| 03/04/2009 | EP2029571A1 Substituted 3 -amino-4 -hydroxy pyrrolidines compounds, their preparation and use as medicaments |
| 03/04/2009 | EP2029558A2 Compounds and methods for modulating fxr |
| 03/04/2009 | EP2029553A1 Substituted pyrazinone derivatives for use as a medicine |
| 03/04/2009 | EP2029552A1 Sulfimides as protein kinase inhibitors |
| 03/04/2009 | EP2029551A2 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/04/2009 | EP2029547A1 Fxr agonists |
| 03/04/2009 | EP2029546A1 Aryl-substituted heterocycles, and use thereof |
| 03/04/2009 | EP2029543A2 Substituted 3-cyanopyridines as protein kinase inhibitors |
| 03/04/2009 | EP2029542A2 Primary amines as renin inhibitors |
| 03/04/2009 | EP2029539A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 03/04/2009 | EP2029535A1 Isoindole derivatives useful for treating pain, gastrointestinal diseases and cancer |
| 03/04/2009 | EP2029529A1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 03/04/2009 | EP1836187B1 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists |
| 03/04/2009 | EP1833795B1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 03/04/2009 | EP1660443B1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 03/04/2009 | EP1551812B1 Mitotic kinesin inhibitors |
| 03/04/2009 | EP1539738B1 Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl -piperidin-1-yl -methanone derivatives, methods for production and use thereof as medicaments |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1452527B1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 03/04/2009 | EP1427720B1 3-substituted-4-pyrimidone derivatives |
| 03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
| 03/04/2009 | EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity |
| 03/04/2009 | CN101379059A N-hydroxyacrylamide compounds |
| 03/04/2009 | CN101379057A Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2- (8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl) eth ylaminoimethyl]} -5-methoxyphenylcarbamoyl) ethyl]piperidin-4-yl es |
| 03/04/2009 | CN101379056A Compounds for the inhibition of integrins and use thereof |
| 03/04/2009 | CN101379055A Substituted quinolones III |
| 03/04/2009 | CN101379054A Piperidine derivatives as CXCR3 receptor antagonists |
| 03/04/2009 | CN101379053A New citrate salt of an indole derivative and its pharmaceutical use |
| 03/04/2009 | CN101379042A Substituted cinnoline derivatives as GABAA-receptor modulators and method for their synthesis |
| 03/04/2009 | CN101379040A Muscarinic receptor antagonists |
| 03/04/2009 | CN101379036A Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 03/04/2009 | CN101379034A Benzamide and heteroarene derivatives as CETP inhibitors |
| 03/04/2009 | CN101379033A Secondary amines |
| 03/04/2009 | CN101379028A Chemical compounds |
| 03/04/2009 | CN101378754A Pharmaceutical use of 2-hydroxy-3- [5- (morpholin-4- ylmethyl) pyridine-2-yl] -1H- indole-5-carbonitrile as a free base or salts |
| 03/04/2009 | CN101376663A 6-benzimidazole-pyridine-2- formiate amide metal complexe, preparation and use |
| 03/04/2009 | CN100465173C A selective kinase inhibitor |
| 03/04/2009 | CN100465163C Cis-2,4,5-triaryl-imidazolines |
| 03/04/2009 | CN100464853C A carbon nitrogen coupling reaction catalyst composed of heterocycle functional group 1,3 diketone and halogenated univalence copper and use thereof |
| 03/04/2009 | CA2697051A1 Substituted-quinoxaline-type piperidine compounds and the uses thereof |
| 03/03/2009 | US7498441 Melanin-concentrating hormone antagonists for eating disorder and diabetes treatment |
| 03/03/2009 | US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine |
| 03/03/2009 | US7498349 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria |
| 03/03/2009 | US7498346 Chemokine receptor binding compounds |
| 03/03/2009 | US7498343 Mycobacterial inhibitors |
| 03/03/2009 | US7498337 Acid secretion inhibitor |
| 03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
| 03/03/2009 | US7498329 5-[(2R,5S)-5-methyl-4-propylmorpholin-2-yl]pyridin-2-amine di-S-camsylate useful for treating sexual, neurodegenerative and psychological disorders; 5-(2-(2-hydroxyethylamino)-1-hydroxyethyl)-2-(2,5-dimethyl-1-pyrrolyl)pyridine or salt intermediate |
| 03/03/2009 | US7498328 Derivatives of sulphonamides, their preparation and use as medicaments |
| 03/03/2009 | US7498324 Substituted lactams as inhibitors of Aβ protein production |
| 03/03/2009 | CA2393197C Control of arthropods in animals with 1-arylpyrazoles |
| 03/03/2009 | CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 02/26/2009 | WO2009026408A1 Therapeutic quinoline and naphthalene derivatives |
| 02/26/2009 | WO2009026407A1 Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity |
| 02/26/2009 | WO2009026326A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | WO2009026319A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | WO2009026276A1 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 02/26/2009 | WO2009026204A1 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
| 02/26/2009 | WO2009025839A2 Phosphodiesterase 10 inhibitors |
| 02/26/2009 | WO2009025823A1 Phosphodiesterase 10 inhibitors |
| 02/26/2009 | WO2009025478A1 Indole and indazole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009025265A1 Piperazine derivative |
| 02/26/2009 | WO2009024825A1 2-pyrazinylbenzimidazole derivatives as receptor tyrosine kinase inhibitors |
| 02/26/2009 | WO2009024611A2 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use |
| 02/26/2009 | WO2009024502A1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/26/2009 | WO2009024342A2 Novel microbiocides |
| 02/26/2009 | WO2009024341A2 Condensed anthran i lami de derivatives as insectisides |
| 02/26/2009 | WO2009024332A1 Pyridoneamide derivatives as focal adhesion kinase (fak) inhibitors and their use for the treatment of cancer |
| 02/26/2009 | WO2009024287A2 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 02/26/2009 | WO2009003998A3 Antiproliferative compounds based on 5-membered heterocycles |
| 02/26/2009 | WO2008140553A3 Mapk/erk kinase inhibitors |
| 02/26/2009 | WO2008115719A9 Fused amino pyridine as hsp90 inhibitors |
| 02/26/2009 | WO2008005368A3 Piperazines as p2x7 antagonists |
| 02/26/2009 | WO2007014226A3 Compounds for the treatment of neurodegeneration and stroke |
| 02/26/2009 | US20090054654 Salt of 1,2-dihydropyridine compound |
| 02/26/2009 | US20090054648 Method for producing asymmetric tetrasubstituted carbon atom-containing compound |
| 02/26/2009 | US20090054644 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/26/2009 | US20090054643 Novel method of synthesis of fluoroquinolones |
| 02/26/2009 | US20090054630 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |